Table 1 Characterization of the population used in the case study
From: Temporal stratification of amyotrophic lateral sclerosis patients using disease progression patterns
PRO-ACT | Lisbon ALS | p-value | |
|---|---|---|---|
n = 3880 | n = 983 | ||
Sex | 4.0 × 10−6 | ||
Male | 2460, 63.4% | 545, 55.4% | – |
Female | 1420, 36.6% | 438, 44.6% | – |
Age at onset (years) | 0 | ||
Median, IQR | 57, 49–64 | 62, 54–71 | – |
Average, Std | 56.20, 11.33 | 61.44, 12.39 | – |
Diagnostic delay (months) | 2.8 × 10−9 | ||
Median, IQR | 9.05, 5.84–13.98 | 10.71, 6.04–17.58 | – |
Average, Std | 11.30, 8.85 | 15.85, 20.19 | – |
BMI at diagnosis (kg/m2) | 0 | ||
Median, IQR | 26.22, 23.33–29.35 | 24.61, 22.60–27.23 | – |
Average, Std | 26.63, 5.31 | 25.01, 13.98 | – |
Onset form | 5.5 × 10−11 | ||
Spinal | 1919, 49.5% | 652, 66.3% | – |
Bulbar | 562, 14.5% | 257, 26.1% | – |
Generalized | 11, 0.3% | 13, 1.3% | – |
Other | 355, 9.1% | 61, 6.2% | – |
C9orf72 | |||
Yes | – | 41, 4.2% | – |
No | – | 454, 46.2% | – |
UMNvsLMN | |||
UMN | – | 166, 16.9% | – |
LMN | – | 404, 41.1% | – |
Both | – | 16, 1.6% | – |